Cures CURES is California's prescription drug monitoring program
Controlled Substance Utilization Review and Evaluation System CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement
CURES - California Department of Consumer Affairs Beginning August 1, 2024, all California dispensers of controlled substances will be required to report dispensations to the Controlled Substance Utilization Review and Evaluation System (CURES) using version 4 2B of the American Society of Automation in Pharmacy (ASAP) format
CURES Regulations - Office of the Attorney General Regulations pertaining to the Controlled Substance Utilization Review and Evaluation System (CURES) can be found at California Code of Regulations, title 11, chapter 8 5
Frequently Asked Questions - Office of the Attorney General The Controlled Substance Utilization Review and Evaluation System (CURES) stores Schedule II, III, IV, and V controlled substance prescription information reported as dispensed in California
Training and Publications - Office of the Attorney General CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, III, IV and V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement
Orphan Cures Act dropped from Senate reconciliation bill The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend an Inflation Reduction Act (IRA) provision currently affecting
CURES - California Board of Registered Nursing The Controlled substance Utilization Review and Evaluation System (CURES), maintained by the Department of Justice (DOJ), tracks all Schedule II, III, and IV controlled substances dispensed in California
CURES Fact Sheet - Medical Board of California The Controlled Substance Utilization Review and Evaluation System (CURES) was certified for statewide use by the Department of Justice (DOJ) on April 2, 2018 Therefore, the mandate to consult CURES prior to prescribing, ordering, administering, or furnishing a Schedule II–IV controlled substance becomes effective on October 2, 2018
Controlled Substance Utilization Review and Evaluation System (CURES) Consulting CURES means the physician prescribing, ordering, administering, or furnishing the Schedule II-IV controlled substance has received a Patient Activity Report (PAR) and has reviewed the information on the document